Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 Infection
Hugo Nodarse-Cuní, Ileana Morales(Ministry of Public Health), Gerardo Guillén(Hunan City University), Ana Aguilera‐Barreto(Centro de Ingeniería Genética y Biotecnología), Dania Vázquez‐Blomquist(Centro de Ingeniería Genética y Biotecnología), Amaylid Arteaga(The Coordinating Center), Odalys Bravo(Ministry of Public Health), Diógenes Quintana(Centro de Ingeniería Genética y Biotecnología), Roberto Cañete Villafranca(University of Matanzas)
Cited by 1
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134